newsfilter
← Latest News
Business Wire·

Athersys Announces 1-for-25 Reverse Stock Split

Athersys, Inc. (NASDAQ:ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1